644 related articles for article (PubMed ID: 9030120)
1. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
Naafs B
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120
[No Abstract] [Full Text] [Related]
2. Azathioprine in controlling type 2 reactions in leprosy: a case report.
Athreya SP
Lepr Rev; 2007 Sep; 78(3):290-2. PubMed ID: 18035780
[No Abstract] [Full Text] [Related]
3. Recognizing and managing the immunologic reactions in leprosy.
Kamath S; Vaccaro SA; Rea TH; Ochoa MT
J Am Acad Dermatol; 2014 Oct; 71(4):795-803. PubMed ID: 24767732
[TBL] [Abstract][Full Text] [Related]
4. Erythema nodosum leprosum necroticans in a child--an unusual manifestation.
Pandhi D; Mehta S; Agrawal S; Singal A
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):122-6. PubMed ID: 16830655
[TBL] [Abstract][Full Text] [Related]
5. Azathioprine as a steroid sparing agent in leprosy type 2 reactions: report of nine cases.
Durães SM; Salles Sde A; Leite VR; Gazzeta MO
Lepr Rev; 2011 Sep; 82(3):304-9. PubMed ID: 22125939
[No Abstract] [Full Text] [Related]
6. [Treatment of erythema nodosum leprosum using thalidomide].
Sheskin J
Acta Leprol; 1983; 1(1):41-50. PubMed ID: 6401140
[No Abstract] [Full Text] [Related]
7. Histoid leprosy with erythema nodosum leprosum--a case report.
Vasavi S; Reddy BS
Indian J Lepr; 2012; 84(1):27-9. PubMed ID: 23077781
[TBL] [Abstract][Full Text] [Related]
8. Thalidomide in the treatment of leprosy.
Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
[TBL] [Abstract][Full Text] [Related]
9. Reaction cases treated at the Regional Leprosy Training and Research Institute, Aska, Orissa: a retrospective analysis.
Santaram V; Porichha D
Indian J Lepr; 2004; 76(4):310-20. PubMed ID: 16119141
[TBL] [Abstract][Full Text] [Related]
10. Severe form of type 2 reaction in patients of Hansen's disease after withdrawal of thalidomide: case reports.
Rattan R; Shanker V; Tegta GR; Verma GK
Indian J Lepr; 2009; 81(4):199-203. PubMed ID: 20704076
[TBL] [Abstract][Full Text] [Related]
11. Effect of zafirlukast on leprosy reactions.
Vides EA; Cabrera A; Ahern KP; Levis WR
Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):71-5. PubMed ID: 10407633
[No Abstract] [Full Text] [Related]
12. Reactive perforating leprosy: pustular erythema nodosum leprosum with epidermal perforation and liberation of Mycobacterium leprae.
Ghorpade A
Int J Dermatol; 2014 Feb; 53(2):221-3. PubMed ID: 24319988
[No Abstract] [Full Text] [Related]
13. Pentoxifylline in the treatment of erythema nodosum leprosum.
De Carsalade GY; Achirafi A; Flageul B
J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
[TBL] [Abstract][Full Text] [Related]
14. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
Sharma NL; Sharma V; Shanker V; Mahajan VK; Sarin S
Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):483-5. PubMed ID: 15755204
[TBL] [Abstract][Full Text] [Related]
15. Necrotic erythema nodosum leprosum with oral mucosal involvement.
Swain JP; Soud A; Agarwal SK
Indian J Lepr; 2008; 80(2):175-8. PubMed ID: 19425513
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
Becx-Bleumink M; Berhe D
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
[TBL] [Abstract][Full Text] [Related]
17. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
18. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum.
Verma KK; Srivastava P; Minz A; Verma K
Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003
[TBL] [Abstract][Full Text] [Related]
19. Erythema leprosum--after treatment of Lepromatous Leprosy.
Eickelmann M; Steinhoff M; Metze D; Tomimori-Yamashita J; Sunderkötter C
J Dtsch Dermatol Ges; 2010 Jun; 8(6):450-3. PubMed ID: 19922466
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor: status in reactions in leprosy before and after treatment.
Bhattacharya SN; Chattopadhaya D; Saha K
Int J Dermatol; 1993 Jun; 32(6):436-9. PubMed ID: 8320025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
